Canyam
AI summaries for academic research
Home
Literature Help
Subscribe
Favorites
Tools
Analysis
Summary
Patents
Not logged in
Back
Journal Details
Nature Reviews Drug Discovery
IF
101.8
Papers
5134
Citations
52850
Related Insights
0
subscribe
Journal Papers
5713
Related Insights
0
Journal Papers
5713
Publication Date
Publication Date
IF
Citations
Drug conjugate allows cell surface payload release
Nature Reviews Drug Discovery
IF
101.8
2026-09-28
0
PRE
AI
Alex Eccleston
Share
Save
From N-of-1 therapy to health-system implementation
Nature Reviews Drug Discovery
IF
101.8
2026-09-25
0
PRE
AI
Haiyan Zhou; Alice E. Davidson; Mina Ryten; Ella F. Whittle; Catherine Ryan; Nick Lench; Daniel J. O’Connor; Carlo Rinaldi; Francesco Muntoni
Share
Save
Refining therapeutic targeting of interleukin-6 by signalling mode selectivity
Nature Reviews Drug Discovery
IF
101.8
2026-09-23
0
PRE
AI
Stefan Rose-John; Georg H. Waetzig; Stefan Schreiber
Share
Save
Navigating ultralarge virtual screening
Nature Reviews Drug Discovery
IF
101.8
2026-09-22
0
PRE
AI
Sarah Crunkhorn
Share
Save
Suppressor tRNA rescues cystic fibrosis
Nature Reviews Drug Discovery
IF
101.8
2026-09-22
0
PRE
AI
Sarah Crunkhorn
Share
Save
Targeting norovirus RNA structures
Nature Reviews Drug Discovery
IF
101.8
2026-09-22
0
PRE
AI
Sarah Crunkhorn
Share
Save
Covalent BAX inhibitor confers cytoprotection
Nature Reviews Drug Discovery
IF
101.8
2026-09-22
0
PRE
AI
Sarah Crunkhorn
Share
Save
Two trials or not two trials? That should not be the question
Nature Reviews Drug Discovery
IF
101.8
2026-09-21
0
PRE
AI
Peter Arlett; Steffen Thirstrup; Francesca Day; Juan Garcia Burgos; Nacho Mbaeliachi; Paolo Foggi; Kit Roes; Emer Cooke; Bruno Sepodes
Share
Save
The evolving landscape of drug targets
Nature Reviews Drug Discovery
IF
101.8
2026-09-21
0
PRE
AI
Liliana Halip; Sorin Avram; John P. Overington; Bissan Al-Lazikani; Ramona Curpan; Suman Sirimulla; Alexei Pushechnikov; Andrea Rosario Beccari; Nikolay Savchuck; Tudor I. Oprea
Share
Save
The value of speed for drug developers
Nature Reviews Drug Discovery
IF
101.8
2026-09-18
0
PRE
AI
David B. Ridley; Chenxi Xu
Share
Save
First myostatin-targeted antibody approved for spinal muscular atrophy
Nature Reviews Drug Discovery
IF
101.8
2026-09-18
0
PRE
AI
Asher Mullard
Share
Save
Selective oestrogen receptor degrader class grows with new cancer approval
Nature Reviews Drug Discovery
IF
101.8
2026-09-11
0
PRE
AI
Asher Mullard
Share
Save
Upcoming FDA approval decisions in Q4 2026
Nature Reviews Drug Discovery
IF
101.8
2026-09-09
0
PRE
AI
Kaniaw Dilzer
Share
Save
A translational framework for extrahepatic oligonucleotide delivery
Nature Reviews Drug Discovery
IF
101.8
2026-09-09
0
PRE
AI
Łukasz Jan Kiełpiński; Felix Franz Schumacher
Share
Save
Un-siloed biomedical opportunities
Nature Reviews Drug Discovery
IF
101.8
2026-09-07
0
PRE
AI
Asher Mullard
Share
Save
Strengthening muscle for healthy ageing: innovative treatments for sarcopenia
Nature Reviews Drug Discovery
IF
101.8
2026-09-07
0
PRE
AI
Sara Ancel; Emmeran Le Moal; Yu Xin Wang; Helen M. Blau
Share
Save
Newest glue degrader nabs multiple myeloma approval
Nature Reviews Drug Discovery
IF
101.8
2026-09-04
0
PRE
AI
Asher Mullard
Share
Save
Click chemistry platform enhances ADC tumour targeting
Nature Reviews Drug Discovery
IF
101.8
2026-09-02
0
PRE
AI
Alex Eccleston
Share
Save
Solute carrier membrane transporters: emerging targets in CNS disorders
Nature Reviews Drug Discovery
IF
101.8
2026-09-01
0
PRE
AI
Yee Kwan Law; Selene Glück; Enrico Girardi; Ariel Bensimon; S. Andreas Angermayr; Giulio Superti-Furga
Share
Save
CAR-T cell therapy for multiple sclerosis
Nature Reviews Drug Discovery
IF
101.8
2026-08-28
0
PRE
AI
Sarah Crunkhorn
Share
Save
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}